Welcome to SepTec

Sepsis causing pathogen diagnostics under 15 minutes

Hero
 About us

About us

SepTec is developing and commercializing a revolutionary sample-to-answer sepsis diagnostic device that can rapidly detect pathogens in whole blood.

Find out more
 Our vision

Our vision

Our mission is to improve healthcare by empowering our customers to effectively treat patients faster than has ever been achieved before.

Find out more
 Our technology

Our technology

A patent pending platform technology - a combination of smart microfluidic engineering, centrifugal forces and sensor fabrication.

Find out more

Latest news

Novus Diagnostics (SepTec) shares valuable insights on the EIC programme and what it takes to be a winner!

Novus Diagnostics (SepTec) shares valuable insights on the EIC programme and what it takes to be a winner!

Co-founder and CSO, Kellie Adamson gives insights into SepTecs journey to date and their most recent €7.4m EIC funding success.

Co-founder and CSO, Kellie Adamson gives insights into SepTecs journey to date and their most recent €7.4m EIC funding success.

Novus Diagnostics (SepTec) wins €7.4m European Innovation Council (EIC) Blended Finance Award.

Novus Diagnostics (SepTec) wins €7.4m European Innovation Council (EIC) Blended Finance Award.

Want to know more?

Want to know the latest tech updates?
Check our Twitter account and don’t forget to follow us.